MersV1, PubMed, Checkpoint, bibRecord, 002038

Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.

Identifieur interne : 002038 ( PubMed/Checkpoint ); précédent : 002037; suivant : 002039

Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.

Auteurs : Morgane Rolland [États-Unis] ; David C. Nickle ; Wenjie Deng ; Nicole Frahm ; Christian Brander ; Gerald H. Learn ; David Heckerman ; Nebosja Jojic ; Vladimir Jojic ; Bruce D. Walker ; James I. Mullins

Source :

PloS one [ 1932-6203 ] ; 2007.

RBID : pubmed:17786195

Descripteurs français

English descriptors

KwdEn :
- Amino Acid Sequence, Enzyme-Linked Immunosorbent Assay, Gene Products, nef (chemistry), Gene Products, nef (immunology), HIV-1 (immunology), Humans, Proteins (chemistry), Proteins (immunology), Proteome, Sequence Homology, Amino Acid, T-Lymphocytes, Cytotoxic (immunology).
MESH :
- chemical , chemistry : Gene Products, nef, Proteins.
- chemical , immunology : Gene Products, nef, Proteins.
- immunology : HIV-1, T-Lymphocytes, Cytotoxic.
- Amino Acid Sequence, Enzyme-Linked Immunosorbent Assay, Humans, Proteome, Sequence Homology, Amino Acid.

Abstract

While human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocytes preferentially target specific regions of the viral proteome, HIV-1 features that contribute to immune recognition are not well understood. One hypothesis is that similarities between HIV and human proteins influence the host immune response, i.e., resemblance between viral and host peptides could preclude reactivity against certain HIV epitopes.

DOI: 10.1371/journal.pone.0000823
PubMed: 17786195

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 002163
to stream PubMed, to step Curation: 002163

Links to Exploration step

pubmed:17786195

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.</title>
<author><name sortKey="Rolland, Morgane" sort="Rolland, Morgane" uniqKey="Rolland M" first="Morgane" last="Rolland">Morgane Rolland</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology, University of Washington, Seattle, Washington, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology, University of Washington, Seattle, Washington</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
<settlement type="city">Seattle</settlement>
</placeName>
<orgName type="university">Université de Washington</orgName>
</affiliation>
</author>
<author><name sortKey="Nickle, David C" sort="Nickle, David C" uniqKey="Nickle D" first="David C" last="Nickle">David C. Nickle</name>
</author>
<author><name sortKey="Deng, Wenjie" sort="Deng, Wenjie" uniqKey="Deng W" first="Wenjie" last="Deng">Wenjie Deng</name>
</author>
<author><name sortKey="Frahm, Nicole" sort="Frahm, Nicole" uniqKey="Frahm N" first="Nicole" last="Frahm">Nicole Frahm</name>
</author>
<author><name sortKey="Brander, Christian" sort="Brander, Christian" uniqKey="Brander C" first="Christian" last="Brander">Christian Brander</name>
</author>
<author><name sortKey="Learn, Gerald H" sort="Learn, Gerald H" uniqKey="Learn G" first="Gerald H" last="Learn">Gerald H. Learn</name>
</author>
<author><name sortKey="Heckerman, David" sort="Heckerman, David" uniqKey="Heckerman D" first="David" last="Heckerman">David Heckerman</name>
</author>
<author><name sortKey="Jojic, Nebosja" sort="Jojic, Nebosja" uniqKey="Jojic N" first="Nebosja" last="Jojic">Nebosja Jojic</name>
</author>
<author><name sortKey="Jojic, Vladimir" sort="Jojic, Vladimir" uniqKey="Jojic V" first="Vladimir" last="Jojic">Vladimir Jojic</name>
</author>
<author><name sortKey="Walker, Bruce D" sort="Walker, Bruce D" uniqKey="Walker B" first="Bruce D" last="Walker">Bruce D. Walker</name>
</author>
<author><name sortKey="Mullins, James I" sort="Mullins, James I" uniqKey="Mullins J" first="James I" last="Mullins">James I. Mullins</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17786195</idno>
<idno type="pmid">17786195</idno>
<idno type="doi">10.1371/journal.pone.0000823</idno>
<idno type="wicri:Area/PubMed/Corpus">002163</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002163</idno>
<idno type="wicri:Area/PubMed/Curation">002163</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002163</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002038</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002038</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.</title>
<author><name sortKey="Rolland, Morgane" sort="Rolland, Morgane" uniqKey="Rolland M" first="Morgane" last="Rolland">Morgane Rolland</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology, University of Washington, Seattle, Washington, United States of America.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology, University of Washington, Seattle, Washington</wicri:regionArea>
<placeName><region type="state">Washington (État)</region>
<settlement type="city">Seattle</settlement>
</placeName>
<orgName type="university">Université de Washington</orgName>
</affiliation>
</author>
<author><name sortKey="Nickle, David C" sort="Nickle, David C" uniqKey="Nickle D" first="David C" last="Nickle">David C. Nickle</name>
</author>
<author><name sortKey="Deng, Wenjie" sort="Deng, Wenjie" uniqKey="Deng W" first="Wenjie" last="Deng">Wenjie Deng</name>
</author>
<author><name sortKey="Frahm, Nicole" sort="Frahm, Nicole" uniqKey="Frahm N" first="Nicole" last="Frahm">Nicole Frahm</name>
</author>
<author><name sortKey="Brander, Christian" sort="Brander, Christian" uniqKey="Brander C" first="Christian" last="Brander">Christian Brander</name>
</author>
<author><name sortKey="Learn, Gerald H" sort="Learn, Gerald H" uniqKey="Learn G" first="Gerald H" last="Learn">Gerald H. Learn</name>
</author>
<author><name sortKey="Heckerman, David" sort="Heckerman, David" uniqKey="Heckerman D" first="David" last="Heckerman">David Heckerman</name>
</author>
<author><name sortKey="Jojic, Nebosja" sort="Jojic, Nebosja" uniqKey="Jojic N" first="Nebosja" last="Jojic">Nebosja Jojic</name>
</author>
<author><name sortKey="Jojic, Vladimir" sort="Jojic, Vladimir" uniqKey="Jojic V" first="Vladimir" last="Jojic">Vladimir Jojic</name>
</author>
<author><name sortKey="Walker, Bruce D" sort="Walker, Bruce D" uniqKey="Walker B" first="Bruce D" last="Walker">Bruce D. Walker</name>
</author>
<author><name sortKey="Mullins, James I" sort="Mullins, James I" uniqKey="Mullins J" first="James I" last="Mullins">James I. Mullins</name>
</author>
</analytic>
<series><title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Gene Products, nef (chemistry)</term>
<term>Gene Products, nef (immunology)</term>
<term>HIV-1 (immunology)</term>
<term>Humans</term>
<term>Proteins (chemistry)</term>
<term>Proteins (immunology)</term>
<term>Proteome</term>
<term>Sequence Homology, Amino Acid</term>
<term>T-Lymphocytes, Cytotoxic (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Humains</term>
<term>Lymphocytes T cytotoxiques (immunologie)</term>
<term>Produits du gène nef ()</term>
<term>Produits du gène nef (immunologie)</term>
<term>Protéines ()</term>
<term>Protéines (immunologie)</term>
<term>Protéome</term>
<term>Similitude de séquences d'acides aminés</term>
<term>Séquence d'acides aminés</term>
<term>Test ELISA</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Gene Products, nef</term>
<term>Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Gene Products, nef</term>
<term>Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Lymphocytes T cytotoxiques</term>
<term>Produits du gène nef</term>
<term>Protéines</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV-1</term>
<term>T-Lymphocytes, Cytotoxic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Humans</term>
<term>Proteome</term>
<term>Sequence Homology, Amino Acid</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Produits du gène nef</term>
<term>Protéines</term>
<term>Protéome</term>
<term>Similitude de séquences d'acides aminés</term>
<term>Séquence d'acides aminés</term>
<term>Test ELISA</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">While human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocytes preferentially target specific regions of the viral proteome, HIV-1 features that contribute to immune recognition are not well understood. One hypothesis is that similarities between HIV and human proteins influence the host immune response, i.e., resemblance between viral and host peptides could preclude reactivity against certain HIV epitopes.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17786195</PMID>
<DateCompleted><Year>2010</Year>
<Month>01</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>2</Volume>
<Issue>9</Issue>
<PubDate><Year>2007</Year>
<Month>Sep</Month>
<Day>05</Day>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.</ArticleTitle>
<Pagination><MedlinePgn>e823</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">While human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocytes preferentially target specific regions of the viral proteome, HIV-1 features that contribute to immune recognition are not well understood. One hypothesis is that similarities between HIV and human proteins influence the host immune response, i.e., resemblance between viral and host peptides could preclude reactivity against certain HIV epitopes.</AbstractText>
<AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">We analyzed the extent of similarity between HIV-1 and the human proteome. Proteins from the HIV-1 B consensus sequence from 2001 were dissected into overlapping k-mers, which were then probed against a non-redundant database of the human proteome in order to identify segments of high similarity. We tested the relationship between HIV-1 similarity to host encoded peptides and immune recognition in HIV-infected individuals, and found that HIV immunogenicity could be partially modulated by the sequence similarity to the host proteome. ELISpot responses to peptides spanning the entire viral proteome evaluated in 314 individuals showed a trend indicating an inverse relationship between the similarity to the host proteome and the frequency of recognition. In addition, analysis of responses by a group of 30 HIV-infected individuals against 944 overlapping peptides representing a broad range of individual HIV-1B Nef variants, affirmed that the degree of similarity to the host was significantly lower for peptides with reactive epitopes than for those that were not recognized.</AbstractText>
<AbstractText Label="CONCLUSIONS/SIGNIFICANCE" NlmCategory="CONCLUSIONS">Our results suggest that antigenic motifs that are scarcely represented in human proteins might represent more immunogenic CTL targets not selected against in the host. This observation could provide guidance in the design of more effective HIV immunogens, as sequences devoid of host-like features might afford superior immune reactivity.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rolland</LastName>
<ForeName>Morgane</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology, University of Washington, Seattle, Washington, United States of America.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Nickle</LastName>
<ForeName>David C</ForeName>
<Initials>DC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Deng</LastName>
<ForeName>Wenjie</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y"><LastName>Frahm</LastName>
<ForeName>Nicole</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y"><LastName>Brander</LastName>
<ForeName>Christian</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Learn</LastName>
<ForeName>Gerald H</ForeName>
<Initials>GH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Heckerman</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jojic</LastName>
<ForeName>Nebosja</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jojic</LastName>
<ForeName>Vladimir</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y"><LastName>Walker</LastName>
<ForeName>Bruce D</ForeName>
<Initials>BD</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mullins</LastName>
<ForeName>James I</ForeName>
<Initials>JI</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>P01 AI057005</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>P30 AI027757</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>AI27757</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>AI57005</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2007</Year>
<Month>09</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015693">Gene Products, nef</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D020543">Proteome</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015693" MajorTopicYN="N">Gene Products, nef</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013602" MajorTopicYN="N">T-Lymphocytes, Cytotoxic</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<GeneralNote Owner="NLM">Original DateCompleted: 20070907</GeneralNote>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year>
<Month>05</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2007</Year>
<Month>05</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>9</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>9</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>9</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17786195</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0000823</ArticleId>
<ArticleId IdType="pmc">PMC1952107</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Nat Rev Immunol. 2006 Mar;6(3):183-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16498449</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 2004 Nov 15;200(10):1243-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15545352</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Blood. 2006 Mar 15;107(6):2373-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16322475</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2006 Apr 1;176(7):4094-101</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16547245</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2006 Mar 31;281(13):8347-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16423825</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Immunol. 2006 May;63(5):338-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16640657</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Rheumatol. 2003 Sep;30(9):2005-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12966606</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7755-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12810958</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bioinformatics. 2007 Sep 1;23(17):2334-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17586542</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Mar;78(5):2187-200</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14963115</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Apr;78(7):3233-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15016844</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2004 Mar 26;337(3):635-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15019783</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1986 Dec;83(23):9188-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3024169</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Rev. 1987 Aug;98:9-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2443443</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1988 Mar 1;167(3):914-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3127528</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Invest. 1989 Apr;83(4):1430-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2467924</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Rheum. 1990 Jun;33(6):774-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2363733</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 1990 Oct 5;215(3):403-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2231712</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Immunol Immunopathol. 1992 Mar;62(3):285-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1371727</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2004 Dec;31 Suppl 1:S26-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15567091</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Mol Cell Biol. 2005 Mar;6(3):197-208</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15738986</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Immunol. 2005 Mar;26(3):166-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15745859</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Genomics. 2005 Apr;85(4):512-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15780754</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Biochem. 2005;74:355-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15952891</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2005 Jun 24;308(5730):1906-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15860590</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Immunol. 2005 Jul;26(7):355-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15922666</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2005 Aug 15;175(4):2252-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16081793</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proteins. 2005;61 Suppl 7:167-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16187359</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proteins. 2005;61 Suppl 7:176-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16187360</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2006 Feb;7(2):173-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16369537</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Today. 1992 Jun;13(6):207-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1627248</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>AIDS Res Hum Retroviruses. 1992 Sep;8(9):1561-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1457201</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 1993 Aug;23(8):2016-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8344367</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 1993 Sep 15;195(2):686-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8373407</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1994 Sep;68(9):6103-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8057491</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1995 Apr 1;181(4):1365-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7699324</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1995 Jun 1;181(6):1945-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7539032</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Rev. 1999 Aug;170:127-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10566147</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunity. 2000 Jan;12(1):83-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10661408</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2000 Jun;74(12):5679-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10823876</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 2000 Jun 5;191(11):1921-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10839807</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2001 Feb 15;409(6822):860-921</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11237011</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2001 Feb;2(2):116-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11175803</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Graph Model. 2001;19(1):26-59</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11381529</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2002 Sep;76(17):8757-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12163596</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2002 Oct;76(20):10155-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12239290</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2003 Jan;3(1):73-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12511877</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Exp Rheumatol. 2003 Mar-Apr;21(2):210-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12747276</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Haematol. 1996 May;93(2):464-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8639450</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1997 Apr 21;185(8):1423-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9126923</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 1997 Sep 1;25(17):3389-402</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9254694</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1997 Oct 30;337(18):1267-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9345075</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cancer Lett. 1998 Feb 27;124(2):213-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9500213</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13153-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9789057</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1999 Feb 5;283(5403):857-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9933172</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Immunol. 1999;17:51-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10358753</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunogenetics. 1999 Oct;49(11-12):957-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10501838</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2006 Mar;80(6):3122-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16501126</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Washington (État)</li>
</region>
<settlement><li>Seattle</li>
</settlement>
<orgName><li>Université de Washington</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Brander, Christian" sort="Brander, Christian" uniqKey="Brander C" first="Christian" last="Brander">Christian Brander</name>
<name sortKey="Deng, Wenjie" sort="Deng, Wenjie" uniqKey="Deng W" first="Wenjie" last="Deng">Wenjie Deng</name>
<name sortKey="Frahm, Nicole" sort="Frahm, Nicole" uniqKey="Frahm N" first="Nicole" last="Frahm">Nicole Frahm</name>
<name sortKey="Heckerman, David" sort="Heckerman, David" uniqKey="Heckerman D" first="David" last="Heckerman">David Heckerman</name>
<name sortKey="Jojic, Nebosja" sort="Jojic, Nebosja" uniqKey="Jojic N" first="Nebosja" last="Jojic">Nebosja Jojic</name>
<name sortKey="Jojic, Vladimir" sort="Jojic, Vladimir" uniqKey="Jojic V" first="Vladimir" last="Jojic">Vladimir Jojic</name>
<name sortKey="Learn, Gerald H" sort="Learn, Gerald H" uniqKey="Learn G" first="Gerald H" last="Learn">Gerald H. Learn</name>
<name sortKey="Mullins, James I" sort="Mullins, James I" uniqKey="Mullins J" first="James I" last="Mullins">James I. Mullins</name>
<name sortKey="Nickle, David C" sort="Nickle, David C" uniqKey="Nickle D" first="David C" last="Nickle">David C. Nickle</name>
<name sortKey="Walker, Bruce D" sort="Walker, Bruce D" uniqKey="Walker B" first="Bruce D" last="Walker">Bruce D. Walker</name>
</noCountry>
<country name="États-Unis"><region name="Washington (État)"><name sortKey="Rolland, Morgane" sort="Rolland, Morgane" uniqKey="Rolland M" first="Morgane" last="Rolland">Morgane Rolland</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002038 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002038 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:17786195
   |texte=   Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:17786195" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021

	Serveur d'exploration MERS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration MERS

Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.

Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki